First-line treatment of apatinib in elderly patient of advanced gastric carcinoma: A case report of NGS-driven targeted therapy

4Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Gastric carcinoma (GC) is a common gastrointestinal malignancy with high incidence and mortality worldwide, and most patients are diagnosed in the late stages of disease. Palliative chemotherapy provides a survival benefit for patients with inoperable advanced GC. However, elderly patients who are unable to tolerate chemotherapy had worse prognosis due to lack of effective treatment. Herein we reported a Chinese elderly GC patient using next generation sequencing (NGS)-based tumor DNA analysis. Valuable gene variants of vascular endothelial growth factor (VEGF) A gene amplification were detected. Additionally, a novel NOTCH1-BPHL fusion has been identified. He received antiangiogenic drug apatinib and showed both good clinical and radiographic response, but eventually died of non-cancer related cause, with progression free survival time (PFS) and overall survival time (OS) up to 9.53 months. This was the first GC case with apatinib usage as first-line treatment under the guidance of NGS gene profiling.

References Powered by Scopus

Cancer statistics in China, 2015

16697Citations
N/AReaders
Get full text

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): A phase 3, open-label, randomised controlled trial

6080Citations
N/AReaders
Get full text

Comprehensive molecular characterization of gastric adenocarcinoma

4853Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Safety and effectiveness of apatinib in elderly patients with metastatic gastric cancer: A sub-analysis from the large-scale, prospective observational study of apatinib for gastric cancer treatment in a real-world clinical setting (AHEAD-G202)

3Citations
N/AReaders
Get full text

New advances in molecular targeted drug therapy and immunotherapy for advanced gastric carcinoma

1Citations
N/AReaders
Get full text

Chinese expert consensus on the clinical application of next-generation sequencing for gastric cancer

0
0Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Yang, Y., Zhang, W., Yao, J., Liu, J., Qin, S., & Wu, Q. (2018). First-line treatment of apatinib in elderly patient of advanced gastric carcinoma: A case report of NGS-driven targeted therapy. Cancer Biology and Therapy, 19(5), 355–358. https://doi.org/10.1080/15384047.2018.1423917

Readers' Seniority

Tooltip

Professor / Associate Prof. 2

40%

PhD / Post grad / Masters / Doc 2

40%

Researcher 1

20%

Readers' Discipline

Tooltip

Nursing and Health Professions 3

50%

Engineering 1

17%

Medicine and Dentistry 1

17%

Veterinary Science and Veterinary Medic... 1

17%

Save time finding and organizing research with Mendeley

Sign up for free